A 60-second, daily summary of the most important data on COVID-19 in the U.S., updated every morning.
The U.S. death toll from the coronavirus topped 200,000 Tuesday, by far the highest in the world, hitting the once-unimaginable threshold.
Arturo Casadevall, professor at Johns Hopkins Bloomberg School of Public Health, on the debate over convalescent plasma as an effective treatment for COVID-19.
Developing, testing and distributing a vaccine is normally a years-long process, but the public need for a COVID-19 vaccine has triggered an unprecedented, accelerated response.
Keshia M. Pollack Porter, PhD, MPH, associate dean for faculty and professor at the Johns Hopkins Bloomberg School of Public Health, on a second public health revolution.
STAT describes possible turning points that could steer the pandemic onto a different course or serve as barometers for how the virus is reshaping our lives.
Dr. Amesh A. Adalja, Johns Hopkins Center for Health Security, on the latest developments in coronavirus and the vaccine race.
As the pandemic continues to put millions at risk daily, including health-care workers, older people and those with pre-existing diseases, who should get vaccinated first?
Johns Hopkins Bloomberg School of Public Health Professor and Virologist Andrew Pekosz on the ebb and flow of COVID-19 in the United States as the nation nears 200,000 virus deaths and steps to try to avoid a second wave of infections.
Dr. Naor Bar-Zeev, associate professor at John Hopkins' Department of International Health, on timelines for a potential COVID-19 vaccine.
Johns Hopkins Assistant Professor of Emergency Medicine Lauren Sauer on the spread of COVID-19 on U.S. college campuses, the slow stream of information on vaccine testing, and the challenge of distributing a coronavirus vaccine.
Caitlin Rivers, senior associate at the Johns Hopkins Center for Health Security, and Nicholas Reich, associate professor and biostatistician at the University of Massachusetts at Amherst, on the unreliability of COVID-19 forecasts.